Getinge First Quarter 2025 Earnings: EPS Misses Expectations

Getinge (STO:GETI B) First Quarter 2025 Results

Key Financial Results

• Revenue: kr8.32b (up 11% from 1Q 2024).
• Net income: kr300.0m (down 35% from 1Q 2024).
• Profit margin: 3.6% (down from 6.1% in 1Q 2024).
• EPS: kr1.10 (down from kr1.69 in 1Q 2024).

Our free stock report includes 3 warning signs investors should be aware of before investing in Getinge. Read for free now.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Getinge EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 31%.

Looking ahead, revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Medical Equipment industry in Sweden.

Performance of the Swedish Medical Equipment industry.

The company's shares are down 7.0% from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 3 warning signs for Getinge you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.